Nifty

:

14677.80

Sensex

:

48732.55

-18.70 (-0.13%)
41.75 (0.09%)

Login

Nifty
Sensex

:
:

14677.80
48732.55

-18.70 (-0.13%)
41.75 (0.09%)

Ortin Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 539287 | NSE: ORTINLAB

Watchlist

NSE BSE

29.70

14-May-2021

Open
High
Low
Previous Close

30.70
31.80
29.55
30.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

35486
10.71
34.10
10.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

24.23
5.26
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

41.30
N/A
1.35

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.75
25.68
35.29

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.75
-0.72
1.02

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

20.61
20.70
16.48

P:BV (Average)

8 Years
5 Years
3 Years

1.25
1.25
1.25

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.59
8.09
7.46

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 51.77 54.14 -4.38% 76.52 30.43 151.46% 78.72 40.58 93.99% 72.25 46.94 53.92%
Expenses 49.61 54.52 -9.01% 72.70 31.02 134.36% 77.18 39.13 97.24% 67.02 44.16 51.77%
EBITDA 2.16 -0.38 - 3.82 -0.60 - 1.55 1.45 6.90% 5.22 2.78 87.77%
EBIDTM 4.18% -0.70% 4.99% -1.96% 1.96% 3.56% 7.23% 5.92%
Other Income 0.12 0.01 1,100.00% 0.19 0.02 850.00% 0.02 0.04 -50.00% 0.12 0.06 100.00%
Interest 0.86 0.79 8.86% 1.06 0.74 43.24% 0.70 0.69 1.45% 0.98 0.90 8.89%
Depreciation 0.53 0.52 1.92% 0.50 0.51 -1.96% 0.51 0.44 15.91% 0.49 0.44 11.36%
PBT 0.89 -1.69 - 2.44 -1.83 - 0.36 0.36 0.00% 3.87 1.49 159.73%
Tax 0.29 0.04 625.00% 0.31 -1.01 - 0.18 0.10 80.00% 2.16 -0.25 -
PAT 0.60 -1.72 - 2.13 -0.82 - 0.17 0.26 -34.62% 1.72 1.74 -1.15%
PATM 1.15% -3.18% 2.78% -2.70% 0.22% 0.64% 2.38% 3.71%
EPS 0.74 -2.13 - 2.62 -1.01 - 0.21 0.32 -34.38% 2.12 2.15 -1.40%

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 279.26 197.39 167.76 79.71 66.75 62.94 60.41 67.14 74.83 85.79 64.99 Net Sales Growth 62.28% 17.66% 110.46% 19.42% 6.05% 4.19% -10.02% -10.28% -12.78% 32.00% Cost Of Goods Sold 225.60 154.62 134.81 57.60 45.59 41.33 41.72 48.66 54.04 66.27 53.33 Gross Profit 53.66 42.77 32.95 22.12 21.16 21.62 18.69 18.47 20.79 19.53 11.66 GP Margin 19.21% 21.67% 19.64% 27.75% 31.70% 34.35% 30.94% 27.51% 27.78% 22.76% 17.94% Total Expenditure 266.51 191.71 161.52 74.31 61.40 57.05 54.14 61.05 68.25 78.85 61.06 Power & Fuel Cost - 5.39 5.67 4.10 4.75 4.68 4.55 3.85 4.12 2.46 1.35 % Of Sales - 2.73% 3.38% 5.14% 7.12% 7.44% 7.53% 5.73% 5.51% 2.87% 2.08% Employee Cost - 4.72 3.68 2.78 2.59 2.13 1.74 1.79 1.85 4.28 1.04 % Of Sales - 2.39% 2.19% 3.49% 3.88% 3.38% 2.88% 2.67% 2.47% 4.99% 1.60% Manufacturing Exp. - 21.18 12.54 5.44 4.70 5.54 3.07 3.53 5.28 0.76 1.83 % Of Sales - 10.73% 7.47% 6.82% 7.04% 8.80% 5.08% 5.26% 7.06% 0.89% 2.82% General & Admin Exp. - 3.78 2.74 3.13 2.79 2.41 2.23 2.55 1.81 3.13 1.50 % Of Sales - 1.91% 1.63% 3.93% 4.18% 3.83% 3.69% 3.80% 2.42% 3.65% 2.31% Selling & Distn. Exp. - 0.38 0.30 0.16 0.38 0.28 0.18 0.27 0.61 0.69 1.74 % Of Sales - 0.19% 0.18% 0.20% 0.57% 0.44% 0.30% 0.40% 0.82% 0.80% 2.68% Miscellaneous Exp. - 1.64 1.78 1.11 0.61 0.68 0.65 0.39 0.55 1.27 1.74 % Of Sales - 0.83% 1.06% 1.39% 0.91% 1.08% 1.08% 0.58% 0.73% 1.48% 0.42% EBITDA 12.75 5.68 6.24 5.40 5.35 5.89 6.27 6.09 6.58 6.94 3.93 EBITDA Margin 4.57% 2.88% 3.72% 6.77% 8.01% 9.36% 10.38% 9.07% 8.79% 8.09% 6.05% Other Income 0.45 0.20 0.57 0.45 0.42 0.57 0.22 0.81 0.24 0.26 0.16 Interest 3.60 3.21 3.22 3.49 2.94 3.42 3.52 3.72 3.55 3.28 1.36 Depreciation 2.03 1.96 1.75 1.69 1.70 1.65 1.64 1.51 1.40 1.33 0.63 PBT 7.56 0.72 1.84 0.68 1.13 1.40 1.33 1.68 1.86 2.59 2.09 Tax 2.94 1.28 0.56 0.00 0.63 0.56 0.44 0.50 0.77 1.31 0.47 Tax Rate 38.89% 177.78% 30.43% 0.00% 55.75% 40.00% 33.08% 29.76% 41.40% 50.58% 22.49% PAT 4.62 -0.56 1.28 0.68 0.50 0.83 0.90 1.19 1.09 1.28 1.62 PAT before Minority Interest 4.62 -0.56 1.28 0.68 0.50 0.83 0.90 1.19 1.09 1.28 1.62 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.65% -0.28% 0.76% 0.85% 0.75% 1.32% 1.49% 1.77% 1.46% 1.49% 2.49% PAT Growth 955.56% - 88.24% 36.00% -39.76% -7.78% -24.37% 9.17% -14.84% -20.99% EPS 5.70 -0.69 1.58 0.84 0.62 1.02 1.11 1.47 1.35 1.58 2.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 23.82 25.09 24.08 23.40 23.27 22.44 21.96 20.78 20.18 19.89 Share Capital 16.94 16.94 16.94 16.94 16.94 16.94 16.94 16.94 16.94 4.70 Total Reserves 6.88 8.15 7.14 6.46 6.33 5.50 5.02 3.84 3.24 2.95 Non-Current Liabilities 8.87 7.82 7.96 7.64 15.81 8.01 5.89 3.98 3.01 13.24 Secured Loans 0.66 0.36 0.18 0.23 0.32 2.27 0.72 0.95 0.36 9.59 Unsecured Loans 4.25 4.38 1.30 1.18 4.48 2.67 2.08 0.11 0.11 1.58 Long Term Provisions 1.43 0.53 0.26 0.25 0.21 0.14 0.11 0.09 0.06 0.00 Current Liabilities 83.83 72.18 41.62 30.50 26.74 37.30 45.01 48.74 59.86 21.44 Trade Payables 60.00 47.60 16.58 7.05 2.81 16.85 26.39 29.53 45.46 18.64 Other Current Liabilities 8.36 9.10 9.99 7.89 8.20 5.16 3.02 2.68 1.31 0.86 Short Term Borrowings 14.67 14.74 14.66 15.12 15.22 14.80 15.22 15.98 11.87 0.00 Short Term Provisions 0.80 0.74 0.39 0.44 0.50 0.49 0.39 0.54 1.23 1.94 Total Liabilities 116.52 105.09 73.66 61.54 65.82 67.75 72.86 73.50 83.05 54.57 Net Block 22.45 21.29 20.03 20.69 21.63 21.83 23.90 24.77 23.85 22.00 Gross Block 29.44 26.32 23.31 22.35 32.93 31.58 31.77 31.23 28.91 25.73 Accumulated Depreciation 6.99 5.03 3.28 1.67 11.30 9.75 7.87 6.46 5.06 3.73 Non Current Assets 24.11 23.05 21.31 23.31 34.64 23.92 26.10 27.08 25.24 22.74 Capital Work in Progress 0.43 0.53 0.40 0.35 0.00 0.00 0.00 0.00 0.00 0.68 Non Current Investment 0.07 0.08 0.08 0.07 0.03 0.03 0.03 0.03 0.03 0.05 Long Term Loans & Adv. 1.15 1.14 0.79 0.95 12.98 2.05 2.17 2.27 1.31 0.00 Other Non Current Assets 0.00 0.00 0.00 1.25 0.00 0.00 0.00 0.00 0.04 0.00 Current Assets 92.41 82.04 52.36 38.22 31.18 43.83 46.76 46.40 57.81 31.65 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 49.90 36.96 24.02 17.65 16.84 21.98 21.72 15.22 11.06 4.36 Sundry Debtors 37.15 37.83 21.85 15.24 9.13 17.14 21.42 27.46 43.86 21.39 Cash & Bank 2.50 2.14 1.69 1.43 1.66 1.74 1.16 1.98 1.01 0.19 Other Current Assets 2.86 0.92 2.54 1.91 3.56 2.98 2.45 1.74 1.89 5.71 Short Term Loans & Adv. 2.75 4.19 2.25 1.99 3.51 2.92 2.33 1.67 1.71 5.66 Net Current Assets 8.59 9.86 10.73 7.72 4.44 6.53 1.75 -2.34 -2.05 10.21 Total Assets 116.52 105.09 73.67 61.53 65.82 67.75 72.86 73.50 83.05 54.57

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 6.23 6.52 1.56 1.94 0.52 -1.38 -1.76 -1.66 0.29 1.57 PBT 0.72 1.84 0.68 1.13 1.40 1.33 1.73 1.80 2.20 2.06 Adjustment 5.41 5.21 1.39 1.69 4.49 4.96 4.64 4.73 4.47 1.27 Changes in Working Capital 0.93 -0.10 0.06 -0.26 -1.46 -3.66 -4.03 -4.26 -2.58 -0.60 Cash after chg. in Working capital 7.06 6.95 2.14 2.56 4.44 2.63 2.33 2.27 4.09 2.73 Interest Paid 0.00 0.00 0.00 0.00 -3.42 -3.52 -3.72 -3.55 -3.28 -0.68 Tax Paid -0.83 -0.42 -0.58 -0.62 -0.50 -0.49 -0.38 -0.38 -0.51 -0.48 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -3.09 -3.27 -0.90 -1.26 -0.86 0.22 -0.03 -2.08 -2.23 -5.74 Net Fixed Assets -3.02 -3.14 -1.01 10.23 -1.35 0.19 -0.54 -2.32 -2.50 -21.10 Net Investments 0.01 0.00 -0.01 -0.04 0.00 0.00 0.00 0.00 0.02 -0.05 Others -0.08 -0.13 0.12 -11.45 0.49 0.03 0.51 0.24 0.25 15.41 Cash from Financing Activity -4.26 -2.89 0.07 -0.82 0.27 1.73 0.97 4.70 1.78 0.87 Net Cash Inflow / Outflow -1.12 0.37 0.73 -0.14 -0.07 0.58 -0.81 0.97 -0.16 -3.31 Opening Cash & Equivalents -12.60 -12.97 -13.69 -13.56 1.74 1.16 1.98 1.01 1.16 2.22 Closing Cash & Equivalent -13.72 -12.60 -12.97 -13.69 1.66 1.74 1.16 1.98 1.01 0.19

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 14.06 14.81 14.21 13.81 13.74 13.25 12.96 12.25 11.91 15.89 ROA -0.51% 1.43% 1.00% 0.79% 1.25% 1.28% 1.62% 1.40% 1.86% 4.68% ROE -2.31% 5.21% 2.86% 2.16% 3.65% 4.04% 5.55% 5.34% 9.24% 22.74% ROCE 8.93% 11.76% 10.14% 9.58% 11.01% 11.55% 13.62% 15.05% 18.30% 16.85% Fixed Asset Turnover 7.08 6.76 3.53 2.41 2.08 2.04 2.29 2.67 3.31 4.48 Receivable days 69.33 64.92 83.96 66.61 71.32 108.74 123.82 162.36 131.58 74.32 Inventory Days 80.31 66.33 94.33 94.29 105.42 123.23 93.58 59.84 31.12 14.59 Payable days 98.39 70.44 60.70 33.70 59.70 146.70 167.17 201.37 152.56 64.64 Cash Conversion Cycle 51.24 60.82 117.59 127.20 117.04 85.28 50.23 20.83 10.13 24.28 Total Debt/Equity 0.82 0.78 0.72 0.74 0.90 0.93 0.85 0.86 0.65 1.50 Interest Cover 1.22 1.57 1.20 1.39 1.41 1.38 1.45 1.52 1.79 2.54

Top Investors:

venkata ramana gaddam

venkata rama gaddam

a prabhakar raju

satyanarayana raju bhupathiraju

a srinivasa raju

alluri maithili

alluri anantha laxmi

shabbir nazmuddin paratha

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback